Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: June-16-16
Credit Expiration Date: June-16-17

Faculty

Doron Schneider, MD
Chief Patient Safety and Quality Officer Abington Health
Deputy Program Director of the Internal Medicine Residency Program
Abington Hospital - Jefferson Health
Abington, PA

Steven Rothman, MD, FACC
Associate Professor of Medicine
Lankenau Institute of Medical Research
Campus Chief, Cardiovascular Diseases
Lankenau Medical Center
Wynnewood, PA

 

Credit Hours

1.0 AMA PRA Category 1 Credit

Medium

Mobile + Online on QuantiaMD

Program Description

Individuals with atrial fibrillation (AF) have a 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most strokes related to AF could be prevented with appropriate anticoagulation therapy, many patients are not receiving it. The goal of this activity is to help clinicians evaluate and optimally manage stroke risk in their patients with AF.

Program Developer/Facilitator


.

Target Audience

This educational activity is designed to meet the needs of internal medicine physicians and other primary care clinicians who treat patients with AF including physician assistants (PAs) and nurse practitioners (NPs).

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Discuss the importance of accurately stratifying AF patients according to stroke risk.
  2. Compare the mechanisms of action, safety, and efficacy of currently available anticoagulants for stroke prevention.
  3. Review current guideline recommendations for anticoagulation in AF patients at risk for stroke.
  4. Outline recent notable changes to standard practice for stroke prevention in AF patients.

Disclosures

Doron Schneider, MD, discloses the following relationships with commercial interests:
Advisory board—Novo Nordisk, Janssen, Lilly
Speakers bureau—Novo Nordisk

Steven Rothman, MD, FACC, discloses the following relationships with commercial interests:
Speakers bureau—Janssen and Boehringer Ingelheim

Rick Ricer, MD, Physician Reviewer, University of Cincinnati, has no conflicts of interest to disclose.
Susan P. Tyler, MEd, CMP, CHCP, FACEHP, University of Cincinnati, has no conflicts of interest to disclose.
Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.
Terry Ann Glauser, MD, MPH, Vice President, Medical Affairs, MCM Education has no conflicts of interest to disclose.

The University of Cincinnati requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports their presentation will not contain reference to investigational and/or off-label uses.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.  

Credit Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release date: June 16, 2016
Last review date: June 16, 2016
Expiration date: June 16, 2017

Commercial Support Statements

This activity is supported by an educational grant from Daiichi Sankyo. 

Instructions

Completion Instructions

  1. Accessing Activity:
    * Click "Start Program" and log into program on QuantiaMD.com
    * Take the pre-test
    * Review the activity
    * Take the post-test and score 80%
    * You are allowed a total of 3 attempts
    * Complete the evaluation
    * View, print, or save a CME certificate verifying your
    credit/participation in this activity
  2. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

Certificate Fee

$0.00

There is no charge for CME credit.

Disclaimer

© 2016 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the University of Cincinnati, or Daiichi Sankyo. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS